Gastroesophageal reflux and idiopathic pulmonary fibrosis: A long term relationship

Respiratory Medicine Case Reports

Volumn 17, Issue , 2016, Pages 40-43

  Gnanapandithan, Karthik ^a   Popkin, Joel H ^b   Devadoss, Ramprakash ^b   Martin, Kevin ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT VINCENT HOSPITAL   (United States)

Author keywords

Acid reflux; Fundoplication; Gastroesophageal reflux; Idiopathic pulmonary fibrosis; Proton pump inhibitor; Pulmonary fibrosis

Indexed keywords

ACETYLCYSTEINE; BOTULINUM TOXIN; OXYGEN; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; BRONCHIECTASIS; CARDIOESOPHAGOMYOTOMY; CASE REPORT; CELIAC DISEASE; CHRONIC ACTIVE INTERSTITIAL PNEUMONITIS; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DYSPNEA; ESOPHAGOGRAPHY; ESOPHAGUS ACHALASIA; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; FEMALE; FIBROSING ALVEOLITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HYPOXIA; INTERSTITIAL PNEUMONIA; LAPAROSCOPIC HELLER MYOTOMY; LIFESTYLE MODIFICATION; LUNG BIOPSY; LUNG FUNCTION TEST; MIDDLE AGED; PRIORITY JOURNAL; RESPIRATORY FAILURE; STOMACH EMPTYING; STOMACH FUNDOPLICATION; THORAX RADIOGRAPHY; VIDEO ASSISTED THORACOSCOPIC LUNG BIOPSY;

EID: 84954307786     PISSN: None     EISSN: 22130071     Source Type: Journal    
DOI: 10.1016/j.rmcr.2016.01.002     Document Type: Article

References (18)

1. Nathan S.D., Shlobin O.A., Weir N., Ahmad S., Kaldjob J.M., Battle E., et al. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 2011, 140(1):221-229.
2. Strieter R.M., Mehrad B. New mechanisms of pulmonary fibrosis. Chest 2009, 136(5):1364-1370.
3. Appel J.Z., Lee S.M., Hartwig M.G., Li B., Hsieh C.C., Cantu E., et al. Characterization of the innate immune response to chronic aspiration in a novel rodent model. Respir. Res. 2007, 8:87.
4. Raghu G., Freudenberger T.D., Yang S., Curtis J.R., Spada C., Hayes J., et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur. Respir. J. 2006, 27(1):136-142.
5. Salvioli B., Belmonte G., Stanghellini V., Baldi E., Fasano L., Pacilli A.M., et al. Gastro-oesophageal reflux and interstitial lung disease. Dig. Liver Dis. 2006, 38(12):879-884.
6. Tobin R.W., Pope C.E., Pellegrini C.A., Emond M.J., Sillery J., Raghu G. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1998, 158(6):1804-1808.
7. Lee J.S., Song J.W., Wolters P.J., Elicker D.M., King T.E., King D.S., et al. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur. Respir. J. 2012, 39(2):352-358.
8. Lee J.S., Collard H.R., Raghu G., Sweet M.P., Hays S.R., Campos G.M., et al. Does chronic microaspiration cause idiopathic pulmonary fibrosis?. Am. J. Med. 2010, 123(4):304-311.
9. Collard H.R., Moore B.B., Flaherty K.R., Brown K.K., Kaner R.J., King T.E., et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007, 176(7):636-643.
10. Fahim A., Crooks M., Hart S.P. Gastroesophageal reflux and idiopathic pulmonary fibrosis: a review. Pulm. Med. 2011, 2011:634613.
11. Raghu G., Yang S.T., Spada C., Hayes J., Pellegrini C.A. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest 2006, 129(3):794-800.
12. Lee J.S., Ryu J.H., Elicker B.M., Lydell C.P., Jones K.D., Wolters P.J., et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2011, 184(12):1390-1394.
13. Lee J.S., Collard H.R., Anstrom K.J., Martinez F.J., Noth I., Roberts R.S. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir. Med. 2013, 1(5):369-376.
14. Hoppo T., Jarido V., Pennathur A., Morrell M., Crespo M., Shigemura N., et al. Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch. Surg. 2011, 146(9):1041-1047.
15. Linden P.A., Gilbert R.J., Yeap B.Y., Boyle K., Deykin A., Jaklitsch M.T., et al. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J. Thorac. Cardiovasc Surg. 2006, 131(2):438-446.
16. Bavishi C., Dupont H.L. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment. Pharmacol. Ther. 2011, 34(11-12):1269-1281.
17. Barletta J.F., Scar D.A. Proton pump inhibitors increase the risk for hospital-acquired clostridium difficile infection in critically ill patients. Crit. Care 2014, 18(6):714.
18. Herzig S.J., Howell M.D., Ngo L.H., Marcantonio E.R. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009, 301(20):2120-2128.